The serum level of IL-10 seemed to be a predictive marker in NSCLC at a later stage, said De vita et al. [84] and Soria et al. [65], reported in NSCLC patients, having a low level of IL-10 expression at the early-stage, considered a shoddy projection. This evidence concerns the gene IL10 and non-small cell lung carcinoma.